{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24774968",
  "DateCompleted": {
    "Year": "2015",
    "Month": "01",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "04",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1186/1475-2891-13-38"
    ],
    "Journal": {
      "ISSN": "1475-2891",
      "JournalIssue": {
        "Volume": "13",
        "PubDate": {
          "Year": "2014",
          "Month": "Apr",
          "Day": "28"
        }
      },
      "Title": "Nutrition journal",
      "ISOAbbreviation": "Nutr J"
    },
    "ArticleTitle": "Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan.",
    "Pagination": {
      "StartPage": "38",
      "MedlinePgn": "38"
    },
    "Abstract": {
      "AbstractText": [
        "Beta-glucans are a heterogeneous group of natural polysaccharides mostly investigated for their immunological effects. Due to the low systemic availability of oral preparations, it has been thought that only parenterally applied beta-glucans can modulate the immune system. However, several in vivo and in vitro investigations have revealed that orally applied beta-glucans also exert such effects. Various receptor interactions, explaining possible mode of actions, have been detected. The effects mainly depend on the source and structure of the beta-glucans. In the meantime, several human clinical trials with dietary insoluble yeast beta-glucans have been performed. The results confirm the previous findings of in vivo studies. The results of all studies taken together clearly indicate that oral intake of insoluble yeast beta-glucans is safe and has an immune strengthening effect."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "analyze & realize GmbH, Waldseeweg 6, 13467 Berlin, Germany. hstier@analyze-realize.com."
          }
        ],
        "LastName": "Stier",
        "ForeName": "Heike",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ebbeskotte",
        "ForeName": "Veronika",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gruenwald",
        "ForeName": "Joerg",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nutr J",
    "NlmUniqueID": "101152213",
    "ISSNLinking": "1475-2891"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunologic Factors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "beta-Glucans"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Immunologic Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "beta-Glucans"
    }
  ]
}